Sean is a computational biologist with extensive academic and industry experience and comes to the team from Compendia Bioscience, with a strong track record of genomic biomarker discovery and target validation. His current efforts are focused on understanding how the underlying genomic and molecular mechanisms of kidney disease can be used to identify promising drug targets.